Related references
Note: Only part of the references are listed.Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ
Michael S. Toss et al.
MODERN PATHOLOGY (2019)
3D organizational mapping of collagen fibers elucidates matrix remodeling in a hormone-sensitive 3D breast tissue model
Zhiyi Liu et al.
BIOMATERIALS (2018)
Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast
Michael S. Toss et al.
MODERN PATHOLOGY (2018)
Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ
Islam M. Miligy et al.
MODERN PATHOLOGY (2018)
Prolyl-4-hydroxylase A subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS)
Michael S. Toss et al.
BRITISH JOURNAL OF CANCER (2018)
Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy
Charu Kothari et al.
Oncotarget (2018)
Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ
Matthew W. Conklin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Identifying progression predictors of breast ductal carcinoma in situ
Joe Yeong et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features
Shona Hendry et al.
CLINICAL CANCER RESEARCH (2017)
The hypoxic tumor microenvironment: A driving force for breast cancer progression
Gregg L. Semenza
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
The immune microenvironment of breast ductal carcinoma in situ
Elizabeth Thompson et al.
MODERN PATHOLOGY (2016)
Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis
Cole R. Drifka et al.
MODERN PATHOLOGY (2015)
Updated UK Recommendations for HER2 assessment in breast cancer
Emad A. Rakha et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Determination of collagen content within picrosirius red stained paraffin-embedded tissue sections using fluorescence microscopy
Benjamin Vogel et al.
METHODSX (2015)
Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer
Anosheh Afghahi et al.
BREAST CANCER RESEARCH (2015)
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
Holly E. Barker et al.
NATURE REVIEWS CANCER (2015)
Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
Michael D. Allen et al.
CLINICAL CANCER RESEARCH (2014)
Collagen as a double-edged sword in tumor progression
Min Fang et al.
TUMOR BIOLOGY (2014)
Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast
S. K. Lee et al.
BRITISH JOURNAL OF SURGERY (2013)
Collagen Prolyl Hydroxylases Are Essential for Breast Cancer Metastasis
Daniele M. Gilkes et al.
CANCER RESEARCH (2013)
Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial
Mila Donker et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
Lawrence J. Solin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers
Petra van der Groep et al.
PLOS ONE (2013)
Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia
Erik S. Knudsen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Differentially Expressed Genes Regulating the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer
Sangjun Lee et al.
CANCER RESEARCH (2012)
Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma
Matthew W. Conklin et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Nomogram for Risk of Relapse After Breast-Conserving Surgery in Ductal Carcinoma In Situ
Chafika Mazouni et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ
Udo Rudloff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF ONCOLOGY PRACTICE (2010)
Collagen density promotes mammary tumor initiation and progression
Paolo P. Provenzano et al.
BMC MEDICINE (2008)
The inhibitory collagen receptor LAIR-1 (CD305)
Linde Meyaard
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Breast density in relation to risk of ductal carcinoma in situ of the breast in women undergoing screening mammography
Todd A. MacKenzie et al.
CANCER CAUSES & CONTROL (2007)
Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ:: indications and utilisation in the UK. Interim findings from the Sloane Project
D. Dodwell et al.
BRITISH JOURNAL OF CANCER (2007)
Biomechanics and biophysics of cancer cells
Subra Suresh
ACTA BIOMATERIALIA (2007)
Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: The University of Michigan experience
Merav A. Ben-David et al.
BREAST JOURNAL (2007)
Collagen reorganization at the tumor-stromal interface facilitates local invasion
Paolo P. Provenzano et al.
BMC MEDICINE (2006)
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-Year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group
Nina Bijker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Inhibition of experimental metastasis by targeting the HUIV26 cryptic epitope in collagen
JM Roth et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms
C Bavik et al.
CANCER RESEARCH (2006)
Tensional homeostasis and the malignant phenotype
MJ Paszek et al.
CANCER CELL (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Intrinsic fibroblast-mediated remodeling of damaged collagenous matrices in vivo
PP Provenzano et al.
MATRIX BIOLOGY (2005)
Molecular characterization of the tumor microenvironment in breast cancer
M Allinen et al.
CANCER CELL (2004)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
The tension mounts: Mechanics meets morphogenesis and malignancy
MJ Paszek et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2004)
Share Paper
